Galectin Therapeutics Inc. appointed Benjamin S. Carson, Sr., M.D. as a new member of the Board of Directors, following his service as a senior advisor to the Company since 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -1.43% | +2.37% | +107.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+107.83% | 214M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GALT Stock
- News Galectin Therapeutics Inc.
- Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors